1 Min Read
Oct 24 (Reuters) - Santhera Pharmaceuticals Holding AG :
* ANNOUNCES START OF PHASE IB/IIA TRIAL WITH POL6014 IN PATIENTS WITH CYSTIC FIBROSIS Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.